Literature DB >> 21171518

Recommendations for mutational analysis of EGFR in lung carcinoma.

A Marchetti1, N Normanno, Carmine Pinto, Gian Luigi Taddei, Vincenzo Adamo, Andrea Ardizzoni, Gerardo Botti, Alberto Bardelli, Camilla Comin, Lucio Crinò, Gabriella Fontanini, Marcello Gambacorta, Antonio Marchetti, Bruno Murer, Nicola Normanno, Oscar Nappi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21171518

Source DB:  PubMed          Journal:  Pathologica        ISSN： 0031-2983


× No keyword cloud information.
  15 in total

Review 1.  Personalized cancer medicine and the future of pathology.

Authors:  H Moch; P R Blank; M Dietel; G Elmberger; K M Kerr; J Palacios; F Penault-Llorca; G Rossi; T D Szucs
Journal:  Virchows Arch       Date:  2011-12-06       Impact factor: 4.064

2.  Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Authors:  Pilar Garrido; Javier de Castro; Ángel Concha; Enriqueta Felip; Dolores Isla; Fernando López-Ríos; Luis Paz-Ares; José Ramírez; Julián Sanz; José Javier Gómez
Journal:  Clin Transl Oncol       Date:  2012-05       Impact factor: 3.405

3.  Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

Authors:  Rodryg Ramlau; Paweł Krawczyk; Rafał Dziadziuszko; Izabela Chmielewska; Janusz Milanowski; Włodzimierz Olszewski; Katarzyna Stencel; Katarzyna Ramlau-Piątek; Agnieszka Segiet; Michał Skroński; Jacek Grudny; Joanna Chorostowska-Wynimko
Journal:  Oncol Lett       Date:  2017-09-07       Impact factor: 2.967

4.  EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).

Authors:  Anita Midha; Simon Dearden; Rose McCormack
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

5.  EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey.

Authors:  Yasushi Yatabe; Keith M Kerr; Ahmad Utomo; Pathmanathan Rajadurai; Van Khanh Tran; Xiang Du; Teh-Ying Chou; Ma Luisa D Enriquez; Geon Kook Lee; Jabed Iqbal; Shanop Shuangshoti; Jin-Haeng Chung; Koichi Hagiwara; Zhiyong Liang; Nicola Normanno; Keunchil Park; Shinichi Toyooka; Chun-Ming Tsai; Paul Waring; Li Zhang; Rose McCormack; Marianne Ratcliffe; Yohji Itoh; Masatoshi Sugeno; Tony Mok
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

6.  Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma.

Authors:  Panagiotis Paliogiannis; Federico Attene; Antonio Cossu; Efisio Defraia; Giuseppe Porcu; Annamaria Carta; Maria Ignazia Sotgiu; Antonio Pazzola; Lorenzo Cordero; Francesca Capelli; Giovanni Maria Fadda; Salvatore Ortu; Giovanni Sotgiu; Grazia Palomba; Maria Cristina Sini; Giuseppe Palmieri; Maria Colombino
Journal:  Mol Med Rep       Date:  2015-02-12       Impact factor: 2.952

7.  Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing.

Authors:  Luisella Righi; Alessandra Cuccurullo; Simona Vatrano; Susanna Cappia; Daniela Giachino; Paolo De Giuli; Mara Ardine; Silvia Novello; Marco Volante; Giorgio V Scagliotti; Mauro Papotti
Journal:  BMC Cancer       Date:  2013-03-13       Impact factor: 4.430

Review 8.  EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.

Authors:  Gillian Ellison; Guanshan Zhu; Alexandros Moulis; Simon Dearden; Georgina Speake; Rose McCormack
Journal:  J Clin Pathol       Date:  2012-11-21       Impact factor: 3.411

9.  Optimizing response to gefitinib in the treatment of non-small-cell lung cancer.

Authors:  Pietro Carotenuto; Cristin Roma; Anna Maria Rachiglio; Raffaella Pasquale; Renato Franco; Giuseppe Antinolfi; Francovito Piantedosi; Alfonso Illiano; Gerardo Botti; Alessandro Morabito; Nicola Normanno; Antonella De Luca
Journal:  Pharmgenomics Pers Med       Date:  2011-03-14

Review 10.  Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review.

Authors:  James Sherwood; Simon Dearden; Marianne Ratcliffe; Jill Walker
Journal:  J Exp Clin Cancer Res       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.